San Francisco, CA, United States of America

George Miljanich

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Adynxx Sub, Inc., Adynxx, Inc.. Active years: 2017-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Miljanich. Retrieved from https://idiyas.com/inventor/george-miljanich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: George Miljanich: Innovator in Active Ingredient Delivery

Introduction

George Miljanich is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of active ingredient delivery, holding 2 patents that focus on innovative formulations. His work has implications for various applications in the pharmaceutical and biotechnology industries.

Latest Patents

Miljanich's latest patents revolve around formulations for the delivery of active ingredients. These inventions relate to in vivo delivery systems that enhance the effectiveness of active ingredients. More specifically, they involve formulations that include an agent, methods for creating these formulations, and techniques for their application.

Career Highlights

Throughout his career, George Miljanich has worked with companies such as Adynxx, Inc. and Adynxx Sub, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the realm of active ingredient delivery.

Collaborations

Miljanich has collaborated with professionals like Julien Mamet and Scott Harris, contributing to a dynamic exchange of ideas and expertise in his field.

Conclusion

George Miljanich's work in active ingredient delivery showcases his innovative spirit and dedication to advancing technology in the pharmaceutical sector. His patents and collaborations reflect a commitment to improving the efficacy of drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…